University of Texas-Arlington: Using Light to Treat Drug-Resistant Tumors
June 30, 2021
June 30, 2021
ARLINGTON, Texas, June 30 (TNSRes) -- The University of Texas Arlington campus issued the following news release:
A chemist at The University of Texas at Arlington is developing a cancer medication that uses light to target and destroy tumor cells in a process known as photodynamic therapy (PDT).
Sherri McFarland, professor of chemistry, and her team of researchers have developed a chemical compound containing the transition metal ruthenium. When ruthenium absorbs light . . .
A chemist at The University of Texas at Arlington is developing a cancer medication that uses light to target and destroy tumor cells in a process known as photodynamic therapy (PDT).
Sherri McFarland, professor of chemistry, and her team of researchers have developed a chemical compound containing the transition metal ruthenium. When ruthenium absorbs light . . .